respiratory syncytial virus

News

AZ, Sanofi's Beyfortus gets CDC okay for RSV prevention

The final obstacle to the routine use of Sanofi and AstraZeneca's Beyfortus to prevent respiratory syncytial virus (RSV) in the US has fallen after it was backed by Centre

News

GSK takes RSV jab rivalry with Pfizer into the courts

GSK has filed a lawsuit against Pfizer in a US court alleging infringement of patents that it holds on vaccines against respiratory syncytial virus (RSV).

News

Beyfortus cleared by FDA for RSV prevention in infants

Sanofi’s plan to become a dominant player in the respiratory syncytial virus (RSV) market has moved a step closer, with FDA approval of Beyfortus for the prevention of RSV

News

Sanofi sets out plan to lead the RSV vaccine market

Sanofi is trailing behind GSK and Pfizer when it comes to vaccines for respiratory syncytial virus (RSV), but it still thinks it can be the top player in the market with a

News

CDC panel backs use of GSK, Pfizer’s RSV shots this year

Adults aged 60 and over in the US will be eligible for vaccinations with respiratory syncytial virus (RSV) vaccines from GSK or Pfizer later this year, if the Centers for

News

FDA advisors back Beyfortus for RSV prevention

An FDA advisory committee has voted in favour of approving AstraZeneca and Sanofi’s one-shot antibody treatment to prevent respiratory syncytial virus (RSV) disease in inf

AZ, Sanofi's Beyfortus gets CDC okay for RSV prevention

GSK takes RSV jab rivalry with Pfizer into the courts

Beyfortus cleared by FDA for RSV prevention in infants

Sanofi sets out plan to lead the RSV vaccine market

CDC panel backs use of GSK, Pfizer’s RSV shots this year

FDA advisors back Beyfortus for RSV prevention

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

respiratory syncytial virus

Editor's Picks